Product Introduction & Formulation Profile

Telmisartan 40 mg + Amlodipine 5 mg + Hydrochlorothiazide 12.50 mg Tablets are a multi-component solid oral pharmaceutical formulation containing three established active pharmaceutical ingredients. The combination is developed as a standardized tablet dosage form with carefully selected excipients to maintain uniformity, physical integrity, and consistent product quality. For pharmaceutical companies expanding their formulation portfolio, this type of combination product represents a technically structured dosage form requiring appropriate consideration of ingredient compatibility, manufacturing parameters, and analytical controls.

The formulation combines Telmisartan 40 mg, Amlodipine 5 mg, and Hydrochlorothiazide 12.50 mg in a single tablet. During development, attention is given to the individual characteristics of each active ingredient as well as their behavior within the complete formulation. A professionally developed product should demonstrate consistent composition and suitable finished-tablet characteristics across manufacturing batches.

For companies operating in the PCD Pharma Franchise segment, a properly manufactured combination tablet can form part of a diversified pharmaceutical portfolio with standardized product presentation.

Active Ingredients & Excipient Selection

The formulation contains three active pharmaceutical ingredients with different physicochemical characteristics. Telmisartan 40 mg is incorporated as one of the principal active components, while Amlodipine 5 mg and Hydrochlorothiazide 12.50 mg complete the combination. Since each ingredient may demonstrate different powder-flow, particle-size, moisture-sensitivity, and compression characteristics, formulation development requires careful evaluation of their compatibility and processing behavior.

Pharmaceutical excipients are selected to support the manufacturing and performance characteristics of the finished tablet. Depending on the formulation technology, these may include diluents, binders, disintegrants, lubricants, glidants, and other functional ingredients. The quantity and selection of each excipient are determined during formulation development rather than simply being added to increase tablet volume.

Uniform blending is particularly important in a multi-active formulation. Appropriate mixing procedures help achieve homogeneous distribution of the active ingredients throughout the powder blend. Excipient compatibility studies and pre-formulation evaluation can further assist in establishing a stable and reproducible formulation.

Tablet Manufacturing & Process Controls

The production of Telmisartan 40 mg + Amlodipine 5 mg + Hydrochlorothiazide 12.50 mg Tablets involves a sequence of controlled manufacturing operations. Raw materials are generally subjected to incoming quality checks before being approved for production. Approved materials are accurately dispensed according to the approved batch manufacturing formula.

Depending on the selected manufacturing process, operations may include sifting, blending, granulation, drying, lubrication, and compression. Process parameters are established to achieve suitable flow and compression characteristics while maintaining uniformity of the active ingredients.

Tablet compression requires particular attention because variables such as compression force, machine speed, powder flow, and tooling configuration can influence the final tablet properties. In-process checks may be performed for tablet weight, thickness, hardness, appearance, and other relevant parameters.

If the formulation incorporates film coating, the coating process is controlled to obtain consistent coverage and an appropriate finished appearance. Coating parameters such as spray rate, inlet conditions, pan speed, and drying conditions may be controlled according to the validated manufacturing process.

Quality Attributes & Laboratory Testing

Quality control provides the analytical foundation for ensuring that the finished product conforms to established specifications. Telmisartan 40 mg + Amlodipine 5 mg + Hydrochlorothiazide 12.50 mg Tablets can undergo a range of physical and chemical evaluations before batch release.

Important quality attributes may include identification of the individual active ingredients, assay, uniformity of dosage units, dissolution characteristics, disintegration, average weight, hardness, friability, thickness, and appearance. Appropriate analytical methods are selected to accurately evaluate the three active pharmaceutical ingredients within the combined dosage form.

Because this is a multi-component formulation, analytical testing requires suitable methods capable of distinguishing and quantifying the individual active ingredients. Method development and validation are therefore important components of pharmaceutical quality control.